Neoplasm, Plasma Cell Clinical Trials

6 clinical trials for Neoplasm, Plasma Cell across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease — RECRUITING · PHASE1
• BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease — RECRUITING · PHASE1
• A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma — RECRUITING · PHASE1
• Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy — COMPLETED · NA
• Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma — OTHER · PHASE1
• Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma — OTHER · PHASE1

Refine this search